<DOC>
	<DOC>NCT01665040</DOC>
	<brief_summary>The primary objective of this study is to investigate patient satisfaction with treatment using a new implantable neurostimulation system for chronic pain of the trunk and/or limbs.</brief_summary>
	<brief_title>Clinical Outcomes Study Using a New Implantable Neurostimulation System for Chronic Intractable Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Pain, Intractable</mesh_term>
	<criteria>Chronic intractable pain of the trunk and/or limbs Documented history of trunk and/or limb pain of at least 180 days Overall pain intensity of at least 5 on a 010 numerical rating scale (OPINRS11) over the past 180 days based on subject recall Pass study site's routine psychological/psychiatric evaluation within 180 days before signing the informed consent Subject is willing and able to comply with all protocolrequired followup evaluations 18 years of age or older when written informed consent is obtained Subject signs informed consent Unable to operate the Precision Spectraâ„¢ System either by self or with a caregiver Primary source of pain is cancerrelated, pelvic, visceral, anginal or migraine Overall pain intensity of always 10 on a 010 numerical rating scale (OPINRS11) over the past 180 days based on subject recall Is a high surgical risk Currently on any anticoagulant medications that cannot be discontinued during perioperative period Subject requires Magnetic Resonance Imaging (MRI) while implanted with lead(s) and/or the Precision Spectra IPG Subject is participating (or intends to participate) in another investigational drug or device clinical trial that may influence the data that will be collected for this study Subjects already implanted with an active implantable device(s) to treat their pain (IPGs, implantable drug pumps, etc) or pacemaker or Implantable Cardiac Defibrillator Patient is a woman who is pregnant (a urine pregnancy test must be performed within 7 days prior to the stimulation trial procedure in women of childbearing potential) or nursing or intends to become pregnant during the course of the trial. Failed to achieve satisfactory relief during the stimulation trial phase</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>neurostimulation</keyword>
	<keyword>spinal cord stimulation</keyword>
	<keyword>peripheral nerve stimulation</keyword>
</DOC>